B Medical’s portfolio includes vaccine transport systems as well as laboratory refrigerators, contact-shock freezers and ultra-low freezers. Credit: Azenta, Inc / PRNewswire.

Life sciences solution provider Azenta has signed an agreement to acquire cold chain solutions manufacturer and distributor B Medical Systems in a deal valued at about $468.7m (€460m).

Under the terms of the definitive agreement, Azenta will acquire B Medical Systems and its subsidiaries from Navis Capital Partners for a cash price of around $417.7m (€410m) payable at closing.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Additionally, the company will make a payment of up to $50.9m (€50m) in cash after achieving certain future performance milestones.

Headquartered in Luxembourg, B Medical systems’ portfolio includes medical refrigeration, blood management solutions and vaccine transport systems, along with real-time monitoring devices.

Its products also include laboratory refrigerators, transport solutions, contact-shock freezers and ultra-low freezers.

The company currently has a base of more than 500,000 installed units in about 150 countries worldwide.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Azenta stated that the acquisition of B Medical systems will complement its cold chain capabilities and add different solutions for reliable transportation of temperature-sensitive samples.

Azenta president and CEO Steve Schwartz said: “We are excited to add B Medical into our growing portfolio of offerings.

“B Medical has done an outstanding job carving out a strong market position in the vaccine cold chain, and we see a breadth of opportunities to drive even further value from the portfolio by leveraging the Azenta platform.”

Azenta offers a complete suite of cold-chain sample management solutions, as well as genomic services, across areas that include advanced cell therapies, clinical research and drug development for academic, pharmaceutical, healthcare institutions and biotech companies across the world.

Taylor Wessing served as legal counsel for the deal while Jefferies acted as the exclusive financial advisor to Azenta.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now